Come up with a name for your new list and we'll add to it:
Kura Oncology raised a round of funding on March 12, 2015. Investors include
Zeta Acquisition Corp III.
Kura Oncology is a clinical-stage biopharmaceutical company, creating personalized therapeutics for patients with cancer. The company's pipeline consists of four potent and selective small molecule dr…